Endothelial cells as target for antiphospholipid antibodies. Human Polyclonal and Monoclonal Anti‐β<sub>2</sub>‐Glycoprotein I Antibodies React In Vitro with Endothelial Cells Through Adherent β<sub>2</sub>‐Glycoprotein I and Induce Endothelial Activation
Nicoletta Del Papa(University of Milan), Pier Luigi Meroni(IRCCS Istituto Auxologico Italiano), Carola Buccellati(University of Milan), Munther A. Khamashta(The King's College), Takayoshi Koike(Hokkaido University), Anǵela Tincani(Azienda Socio Sanitaria Territoriale degli Spedali Civili di Brescia), Kenji Ichikawa(Eisai (Japan)), G. Balestrieri(Azienda Socio Sanitaria Territoriale degli Spedali Civili di Brescia), L Guidali(University of Milan), Graham R.V. Hughes(King's College London), Angelo Sala(University of Milan)
Cited by 290
Related Papers
International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS)
|Journal of Thrombosis and Haemostasis|2006|7.1k
The “Primary” Antiphospholipid Syndrome
|Medicine|1989|963
EULAR recommendations for the management of systemic lupus erythematosus: 2023 update
|Annals of the Rheumatic Diseases|2023|913
Nitrogen and phosphorus constrain the CO2 fertilization of global plant biomass
|Nature Climate Change|2019|528